References

McGurk M, Escudier MP, Thomas BL, Brown JE. A revolution in the management of obstructive salivary gland disease. Dent Update. 2006; 33:28-36
Cawson R, Odell EW. Cawson's Essential of Oral Pathology and Oral Medicine, 9th edn. : Elsevier; 2017
Leung A, Choi M, Wagner G. Multiple sialoliths and a sialolith of unusual size in the submandibular duct. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999; 87:331-333
McGurk M, Escudier M, Brown J. Modern management of salivary calculi. Br J Surg. 2005; 91:107-112
Goncalves M, Schapher M, Iro H Value of sonography in the diagnosis of sialolithiasis: comparison with the reference standard of direct stone identification. J Ultrasound Med. 2017; 36:2227-2235
Cordesmeyer R, Winterhoff J, Kauffmann P, Laskawi R. Sialoendoscopy as a diagnostic and therapeutic option for obstructive diseases of the large salivary glands—a retrospective analysis. Clin Oral Invest. 2016; 20:1065-1070
Dulguerov P, Marchai F, Lehmann W. Postparotidectomy facial nerve paralysis: possible etiologic factors and results with routine facial nerve monitoring. Laryngoscope. 1999; 109:754-762
Raad I, Sabbagh M, Caranasos G. Acute bacterial sialadenitis: a study of 29 cases and review. Clin Infect Dis. 1990; 12:591-601
Su S, Chang H, Chen K. Current status of mumps virus infection: epidemiology, pathogenesis, and vaccine. Int J Environ Res Public Health. 2020; 17
Aasheim ET, Inns T, Trindall A Outbreak of mumps in a school setting, United Kingdom, 2013. Hum Vaccin Immunother. 2014; 10:2446-2449
Hviid A, Rubin S, Mühlemann K. Mumps. Lancet. 2008; 371:932-944
Scully C, Bagán J, Eveson J Sialosis: 35 cases of persistent parotid swelling from two countries. Br J Oral Maxillofac Surg. 2008; 46:468-472
Scully C, Porter S. Orofacial disease: update for the clinical team: 9. Orofacial pain. Dent Update. 1999; 26:410-417
Voulgarelis M, Dafni U, Isenberg D, Moutsopoulos H. Malignant lymphoma in primary Sjogren's syndrome: a multicenter, retrospective, clinical study by the European concerted action on Sjogren's syndrome. Arthritis Rheum. 1999; 42:1765-1772
Felix D, Luker J, Scully C. Oral medicine: 4. Dry mouth and disorders of salivation. Dent Update. 2012; 39:738-743
Public Health England. Delivering better oral health: an evidence-based toolkit for prevention. Summary guidance tables. 2014. https://www.gov.uk/government/publications/delivering-better-oral-health-an-evidence-based-toolkit-for-prevention (accessed March 2022)
Scully C. Drug effects on salivary glands: dry mouth. Oral Dis. 2003; 9:165-176
Lakraj A, Moghimi N, Jabbari B. Sialorrhea: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins. Toxins. 2013; 5:1010-1031
Office for National Statistics. Cancer registration statistics, England. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcareconditionsanddiseasesbulletinscancerregistrationstatisticsengland/2017 (accessed March 2022)
Mozaffari H, Ramezani M, Janbakhsh A, Sadeghi M. Malignant salivary gland tumors and Epstein–Barr virus (EBV) infection: a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2017; 18:1201-1206
Dong C, Hemminki K. Second primary neoplasms among 53,159 haematolymphoproliferative malignancy patients in Sweden, 1958–1996: a search for common mechanisms. Br J Cancer. 2001; 85:997-1005
Shebl F, Bhatia K, Engels E. Salivary gland and nasopharyngeal cancers in individuals with acquired immunodeficiency syndrome in United States. Int J Cancer. 2010; 126:2503-2508
Sood S, McGurk M, Vaz F. Management of salivary gland tumours: United Kingdom national multidisciplinary guidelines. J Laryngol Otol. 2016; 130:(S2)S142-S149
To V, Chan J, Tsang R, Wei W. Review of salivary gland neoplasms. ISRN Otolaryngol. 2012:1-6
Millsop JW, Wang EA, Fazel N. Etiology, evaluation, and management of xerostomia. Clin Dermatol. 2017; 35:468-476

An overview of the diagnosis and management of non-neoplastic salivary gland pathologies

From Volume 49, Issue 5, May 2022 | Pages 403-406

Authors

Neel Sethi

BDS(Dis), MFDS RCS Ed, PgCert

Dental Core Trainee, Musgrove Park Hospital

Articles by Neel Sethi

Email Neel Sethi

Alessandra Joelle Booth

BDS (Hons), BSc, AKC

Dental Core Trainee, Musgrove Park Hospital

Articles by Alessandra Joelle Booth

Nikul Patel

BDS, MFDS RCS Ed

Specialty Doctor Oral and Maxillofacial Surgery, Musgrove Park Hospital

Articles by Nikul Patel

Graham Merrick

FRCS, FRCS (OMFS), FDSRCS, BDS, MB ChB(Hons)

Consultant in Oral and Maxillofacial Surgery, Musgrove Park Hospital

Articles by Graham Merrick

Abstract

Salivary gland pathologies can be caused by obstruction, inflammation, bacterial or viral infections and neoplasia. Patients can present with acute or chronic presentations of salivary gland disease. Salivary gland disorders can have a significant impact on a patient's systemic health, oral health and quality of life. This article aims to increase awareness of salivary gland pathologies and how they may present in practice. It aims to offer general dental practitioners an understanding of how salivary gland disease can be managed in primary care and which conditions may warrant referral to secondary care, including suspected malignancy. The dental profession has a duty of care to recognize pathologies and treat or refer patients. This article provides an overview of non-neoplastic salivary gland disease, including diagnoses, management and when to refer to secondary care.

CPD/Clinical Relevance: It is important to understand the signs, symptoms and management of non-neoplastic salivary gland diseases, and when to refer patients to secondary care.

Article

Salivary glands are vital to the maintenance of good oral health. They are exocrine glands that produce saliva, which is essential to ensure lubrication of the oral cavity, aid in the digestion of food and act as a buffer to protect the teeth. Anatomically, there are three pairs of major salivary glands, the parotid, submandibular and sublingual glands. Minor salivary glands are numerous and can be found throughout the mucosa lining the oral cavity with the exception of the gingiva. Salivary gland disease can present as a range of pathologies from stones, obstructions and infections through to benign or malignant tumours. This article focuses on non-neoplastic salivary gland pathologies, their diagnosis, management and the role of the general dental practitioner (GDP) in managing patients with salivary gland disease.

Obstructive salivary gland disease is the most common salivary gland pathology to present to general dental practitioners.1 Patients suffering from obstructive salivary disease may complain of intermittent pain and swelling. There are two patterns. The first is related to a stone that presents classically as an acute swelling at meal times. This is typically intermittent and generally resolves over a 30-minute period after eating, as saliva gently oozes past the stone. The second is obstruction by a mucous plug, which tends to happen at breakfast or after a patient has become dehydrated, that can lead to sluggish saliva flow and plug formation. Commonly known as ‘mealtime syndrome,’ saliva production stimulated by the process or thought of eating causes a build-up of saliva in the affected gland and consequential postprandial swelling. In addition to this, after a period, patients with stones may experience repeated episodes of bacterial infections causing suppuration from the gland duct opening and possible systemic symptoms of fever and malaise. Mucous plugs seldom cause infection.

Register now to continue reading

Thank you for visiting Dental Update and reading some of our resources. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Up to 2 free articles per month
  • New content available